Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

Cell

Volumn 68, Issue 3, 1992, Pages 421-427

  Dürkop, Horst ^a   Latza, Ute ^a   Hummel, Michael ^a   Eitelbach, Florian ^a   Seed, Brian ^b   Stein, Harald ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIZIPHUS MAURITIANA; PHRAGMITES;

CD30 ANTIGEN; COMPLEMENTARY DNA; EPITOPE; MONOCLONAL ANTIBODY; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOBLAST; CELL GROWTH; DNA SEQUENCE; HODGKIN DISEASE; HUMAN; HUMAN CELL; MOLECULAR CLONING; PATHOGENESIS; PRIORITY JOURNAL; REED STERNBERG CELL; SIGNAL TRANSDUCTION; T LYMPHOBLAST;

AMINO ACID SEQUENCE; ANTIGENS, CD; ANTIGENS, CD30; ANTIGENS, NEOPLASM; BASE SEQUENCE; CLONING, MOLECULAR; DNA; GENE EXPRESSION; HODGKIN DISEASE; HUMAN; MOLECULAR SEQUENCE DATA; RECEPTORS, CELL SURFACE; RECEPTORS, NERVE GROWTH FACTOR; SEQUENCE ALIGNMENT; SUPPORT, NON-U.S. GOV'T; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0026601968     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(92)90180-K     Document Type: Article

References (63)

1. A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts
2. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system
3. Site-directed ribose methylation identifies 2′-OH groups in polyadenylation substrates critical for AAUAAA recognition and poly(A) addition
4. The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma
5. Transcription termination and 3′ processing: the end is in site!
6. Growth of normal T lymphocytes by monoclonal antibody to the T cell antigen receptor
7. Breast tumor cell lines from pleural effusions
8. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
9. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complex)
10. Characteristics of Hodgkin's disease-derived cell lines
11. Hodgkin's disease, establishment and characterization of four in vitro cell lines
12. High efficiency transformation of E. coli by high voltage electroporation
13. Two tumor necrosis factor-binding proteins purified from human urine
14. Purification of large double-stranded cDNA fragments
15. Biochemical characterization and biosynthesis of the Ki-1 antigen in Hodgkin-derived and virus-transformed human B and T lymphoid cell lines
16. Rapid production of full-length DNA from rare transcripts: amplification using a single gene-specific oligonucleotide primer
17. A simple and very efficient method for generating cDNA libraries
18. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains
19. Protein kinase activity of the intracellular but not the membrane-associated form of the Ki-1 antigen (CD30)
20. A new method for predicting signal sequence cleavage sites
21. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor
22. Vaccinia virus homologues of the shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family
23. Constructing and screening cDNA libraries in lambda gt 10 and lambda gt 11
24. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
25. Expression and structure of the human NGF receptor
26. Phenotypic analysis of an established cell line derived from a patient with Hodgkin's disease (HD)
27. Cytochemical, immunological, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease
28. The trk proto-oncogene encodes a receptor for nerve growth factor
29. A second tumor necrosis factor receptor gene product can shed a naturally occuring tumor necrosis factor inhibitor
30. Point mutations define a sequence flanking the AUG initiation codon that modulates translation by eukaryotic ribosomes
31. cDNA sequences of two inducible T-cell clones
32. A simple method for displaying the hydropathic character of a protein
33. Activation of the transforming potential of the human fos proto-onogene requires message stabilization and results in increased amounts of partially modified fos protein
34. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
35. A new superfamily of cell surface proteins related to the nerve growth factor receptor
36. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes—a molecule related to nerve growth factor receptor
37. Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation
38. Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis
39. Biochemical and structural properties of a Hodgkin's disease related membrane protein
40. Molecular characterization of novel reciprocal translocation t(6; 14) in an Epstein-Barr virus transformed B cell precursor
41. Improved tools for biological sequence comparison
42. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
43. trking neurotrophic receptors
44. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis
45. DNA sequencing with chain-terminating inhibitors
46. Two neoplastic cell lines with unique features derived from Hodgkin's disease
47. Molecular cloning and expression of a receptor for human tumor necrosis factor
48. Production of a monoclonal antibody specific for Hogdkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells
49. Cluster report: CD30
50. Ber-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope
51. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure
52. A conserved AU sequence from 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation
53. Point mutations in AAUAAA and the poly (A) addition site: effects on the accuracy and efficiency of cleavage and polyadenylation in vitro
54. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins
55. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas
56. Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newly-detected small cell population
57. The expression of Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
58. Immunology of Hodgkin and Reed-Sternberg cells
59. Establishment and characterization of a human histiocytic lymphoma cell line (U-937)
60. Purification and properties of biologically active messenger RNA for a myeloma light chain
61. Hybridiźation of denatured RNA and small DNA fragments transferred to nitrocellulose